Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Probi AB (publ)
  6. News
  7. Summary
    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
Delayed Quote. Delayed Nasdaq Stockholm - 08/04 11:29:52 am
465 SEK   -3.83%
07/16Probi Seeks Acquisitions
CI
07/16Q2 2021 : Probi enters new strategic partnerships
AQ
07/16Probi AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Probi : Change in the number of shares and votes in Probi

05/31/2021 | 02:01am EDT

In accordance with the resolution at the Annual General Meeting of Probi AB (publ) on May 7, 2021, the number of shares and votes in Probi has decreased during May 2021 through the cancellation of 250,000 own shares.

Prior to the cancellation of own shares, there were a total of 11,644,125 shares and votes in Probi. The number of shares and votes decreased through the withdrawal by 250,000. Following the completion of the withdrawal, there are a total of 11,394,125 shares and votes in Probi as of May 31, 2021.


For further information, please contact:

Henrik Lundkvist, CFO: tel + 46 46 286 89 41, e-mail: henrik.lundkvist@probi.com

 

This information is information that Probi is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out below, at 8.00 CET on 31 May 2021.
 

ABOUT PROBI
 Probi® is a global company focused exclusively on researching, manufacturing, and delivering probiotics for supplements and functional food. The company is an expert in managing stable, live bacteria from research through every stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics available to people everywhere. Since the company was founded in 1991 at Lund University in Sweden, Probi has expanded its operations to more than 40 markets and holds more than 400 patents worldwide. Probi had sales of SEK 717 m in 2020. Probi's shares are listed on Nasdaq Stockholm, Mid-cap. and there were around 4,000 shareholders on December 31, 2020.

https://news.cision.com/probi/r/change-in-the-number-of-shares-and-votes-in-probi,c3356358

https://mb.cision.com/Main/1556/3356358/1424419.pdf

(c) 2021 Cision. All rights reserved., source Press Releases - English

Stocks mentioned in the article
ChangeLast1st jan.
PROBI AB (PUBL) -3.83% 465 Delayed Quote.14.57%
SYMRISE AG 0.16% 123.9 Delayed Quote.14.11%
All news about PROBI AB (PUBL)
07/16Probi Seeks Acquisitions
CI
07/16Q2 2021 : Probi enters new strategic partnerships
AQ
07/16Probi AB Publ Reports Earnings Results for the Second Quarter Ended June 30, ..
CI
07/13PROBI : Presentation of Probi's Q2 report 2021
PU
07/13PROBI : Presentation of Probi's Q2 report 2021
AQ
07/06PROBI : Snaps Up 13% Stake In Blis Technologies For $6 Million
MT
07/06PROBI : acquires newly issued shares in New Zealand's Blis...
PU
07/06Probi acquires newly issued shares in New Zealand's Blis Technologies and ent..
AQ
07/06Blis Technologies and Probi AB Signs a Licensing and Distribution Agreement
CI
06/15PROBI : and Oriflame enter partnership for digestive...
PU
More news
Financials
Sales 2021 712 M 82,7 M 82,7 M
Net income 2021 95,0 M 11,0 M 11,0 M
Net cash 2021 251 M 29,2 M 29,2 M
P/E ratio 2021 55,6x
Yield 2021 0,26%
Capitalization 5 298 M 615 M 616 M
EV / Sales 2021 7,09x
EV / Sales 2022 5,87x
Nbr of Employees -
Free-Float 36,6%
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Last Close Price 465,00 SEK
Average target price 505,00 SEK
Spread / Average Target 8,60%
EPS Revisions
Managers and Directors
Tom Juhani R÷nnlund Chief Executive Officer
Henrik Lundkvist Chief Financial Officer
Jean-Yves Parisot Chairman
Niklas Brandt Vice President-Information Technology
Niklas Larsson Lead Scientific Affairs
Sector and Competitors
1st jan.Capi. (M$)
PROBI AB (PUBL)14.57%640
NESTLÉ S.A.9.44%346 893
MONDELEZ INTERNATIONAL, INC.8.40%88 594
YIHAI KERRY ARAWANA HOLDINGS CO., LTD-33.47%61 176
DANONE18.36%49 095
THE KRAFT HEINZ COMPANY12.35%47 629